At Certara, we’re proud to support WBUR, Boston’s NPR.
Certara supports public radio because NPR is aligned with our values and helps us spread…
CertaraOctober 29, 2025
Key Lessons & Opportunities in applying NCA and PopPK to ADCs
Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…
CertaraOctober 24, 2025
Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…
CertaraOctober 20, 2025
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
CertaraOctober 15, 2025
MBMA vs. Meta-Analysis: Quick Comparison Guide
Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…
CertaraOctober 8, 2025
U.S. International Reference Pricing: Global Implications and Pharma Strategy
Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could…
CertaraOctober 6, 2025
